Abbott Laboratories S (ABT)

Switzerland
Currency in CHF
106.00
0.00(0.00%)
Closed·
ABT Scorecard
Full Analysis
Has raised its dividend for 11 consecutive years
Trading near 52-week High
Fair Value
Day's Range
106.00106.00
52 wk Range
92.00106.00
Key Statistics
Edit
Bid/Ask
105.00 / 109.00
Prev. Close
104
Open
106
Day's Range
106-106
52 wk Range
92-106
Volume
-
Average Volume (3m)
1
1-Year Change
13.98%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Abbott Laboratories News & Analysis

Show more

Abbott Laboratories Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Employees
114000

Compare ABT to Peers and Sector

Metrics to compare
ABT
Peers
Sector
Relationship
P/E Ratio
17.2x−26.3x−0.5x
PEG Ratio
0.12−0.460.00
Price/Book
4.7x4.8x2.6x
Price / LTM Sales
5.5x4.0x3.0x
Upside (Analyst Target)
-53.8%52.6%
Fair Value Upside
Unlock−26.6%8.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.73%
Dividend Yield
1.82%
Industry Median 1.51%
Annualised payout
1.93
Paid quarterly
5-Years Growth
+10.89%
Growth Streak

Earnings

Latest Release
Apr 16, 2025
EPS / Forecast
0.8888 / 0.9542
Revenue / Forecast
8.45B / 9.29B
EPS Revisions
Last 90 days

People Also Watch

977.68
NOW
+0.64%
102.68
FTNT
+2.83%
145.19
RTX
-0.99%
300.32
UNH
-0.56%

FAQ

What Is the Abbott Laboratories (ABT) Share Price Today?

The live Abbott Laboratories share price today is 106.00.

What Stock Exchange Does Abbott Laboratories (ABT) Trade On?

Abbott Laboratories is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Ticker (Stock Symbol) for Abbott Laboratories?

The stock symbol (also called a 'ticker') for Abbott Laboratories is "ABT."

Does Abbott Laboratories Pay Dividends? What’s The Current ABT Dividend Yield?

Yes, ABT Pays Dividends to its Shareholders. The current Abbott Laboratories dividend yield is 1.81%.

What Is the Current Abbott Laboratories Market Cap?

As of today, Abbott Laboratories market capitalisation is 187.72B.

What Is Abbott Laboratories's (ABT) Earnings Per Share (TTM)?

The Abbott Laboratories EPS 7.73 (Trailing Twelve Months).

When Is the Next Abbott Laboratories Earnings Date?

Abbott Laboratories's next earnings report will be released on 16 Jul 2025.

Is ABT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Abbott Laboratories moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Abbott Laboratories Stock Split?

Abbott Laboratories has split 0 times. (See the ABT stock split history page for full effective split date and price information.)

How Many Employees Does Abbott Laboratories Have?

Abbott Laboratories currently has 114000 employees.

What is the current trading status of Abbott Laboratories (ABT)?

As of 23 Jun 2025, Abbott Laboratories (ABT) is trading at a price of 106.00, with a previous close of 104.00. The stock has fluctuated within a day range of 106.00 to 106.00, while its 52-week range spans from 92.00 to 106.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.